Nantkwest Inc CS (NK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NK | DNLI | MLTX | ||
| Company | Nantkwest Inc CS | Denali Therapeutics Inc | Moonlake Immunotherapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 30.34 | 24.32 | 52.30 | ||
| High | 33.15 | 24.73 | 54.93 | ||
| Low | 29.74 | 23.97 | 51.42 | ||
| Last | 32.49 | 24.69 | 54.32 | ||
| Change | +4.21 | +0.47 | +2.46 | ||
| % Change | +14.89% | +1.94% | +4.74% | ||
| Volume | 1,109,000 | 830,300 | 223,300 | ||
| 20-Day Average Volume | 1,620,320 | 941,500 | 244,515 | ||
| Previous Close | 28.28 | 24.22 | 51.86 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 31.51 | 27.35 | 49.82 | ||
| 20-Day Raw Stochastic | 41.94% | 11.84% | 93.70% | ||
| 20-Day Relative Strength | 58.89% | 41.87% | 59.18% | ||
| Weighted Alpha | +342.67 | +21.93 | +20.89 | ||
| Today's Opinion | 100% Buy | 24% Buy | 88% Buy | ||
| Previous Opinion | 80% Buy | 24% Buy | 88% Buy | ||
| Last Month's Opinion | 100% Buy | 56% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +14.56% since 03/02/21 | -1.44% since 11/15/24 | +11.24% since 11/15/24 | ||
| Low | 23.15 on 03/05/21 | 23.53 on 11/19/24 | 47.33 on 11/18/24 | ||
| High | 33.15 on 03/09/21 | 25.35 on 11/18/24 | 54.93 on 11/22/24 | ||
| 1-Month | |||||
| %Chg | +15.79% since 02/09/21 | -6.09% since 10/22/24 | +13.17% since 10/22/24 | ||
| Low | 23.15 on 03/05/21 | 23.53 on 11/19/24 | 45.24 on 10/31/24 | ||
| High | 45.42 on 02/22/21 | 33.33 on 11/11/24 | 54.93 on 11/22/24 | ||
| 3-Month | |||||
| %Chg | +216.36% since 12/09/20 | +3.35% since 08/22/24 | +11.79% since 08/22/24 | ||
| Low | 10.00 on 12/10/20 | 23.53 on 11/19/24 | 44.71 on 09/06/24 | ||
| High | 45.42 on 02/22/21 | 33.33 on 11/11/24 | 56.00 on 10/07/24 | ||
| 6-Month | |||||
| %Chg | +393.77% since 09/09/20 | +23.08% since 05/22/24 | +36.11% since 05/22/24 | ||
| Low | 6.51 on 09/11/20 | 17.93 on 05/29/24 | 37.55 on 06/24/24 | ||
| High | 45.42 on 02/22/21 | 33.33 on 11/11/24 | 56.00 on 10/07/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,552,620 | 3,553,434 | 3,471,319 | ||
| Shares Outstanding, K | 109,345 | 143,922 | 63,905 | ||
| Annual Sales | 110,000 | 330,530,000 | 0 | ||
| Annual Net Income | -92,380,000 | -145,220,000 | -36,010,000 | ||
| Last Quarter Sales | 20,000 | 0 | 0 | ||
| Last Quarter Net Income | -32,140,000 | -107,190,000 | -35,390,000 | ||
| 60-Month Beta | 2.38 | 1.40 | 1.28 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.63 on 11/06/24 | -0.56 on 11/07/24 | ||
| Latest Earnings Date | 03/24/21 | 11/05/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||